Background: Previous research suggests that locus coeruleus (LC) integrity may partially underlie cognitive reserve (CR), as demonstrated by positive associations between composite measures of CR and MRI-based integrity of the LC, one of the first regions in the brain to accumulate tau pathology. We investigated whether higher MRI-based integrity of the LC confers resilience to cognitive decline related to Alzheimer's disease pathology in individuals with higher cognitive reserve.

Method: Individuals (n = 154) with LC-MRI, 18F-Flortaucipir (FTP-tau), and 11C-Pittsburgh Compound-B (PIB-amyloid) PET were selected from the Harvard Aging Brain Study (Figure 1). Cognition over time was modeled using the PACC5 composite score. CR was quantified using a composite of verbal IQ, years of education, and occupational attainment (i.e., Hollingshead score). We used a data-driven approach to cluster participants on the basis of both their CR and AD pathology. K-means clustering was performed to group individuals based on CR and entorhinal FTP, FTP-based Braak stage III or IV composites, or neocortical PiB. The relationship between LC MRI-integrity and cognition over time across the cluster-derived pathology-cognitive reserve groups was assessed using linear mixed effects modeling (adjusted for age and sex).

Result: Cluster analysis consistently identified three groups (Figure 2, left side): High pathology/high CR; low pathology/high CR, and low pathology/low CR. Throughout all analyses, the high pathology/high CR cluster showed less steep cognitive decline over time in a dose-response manner of LC integrity (Figure 3, right side). Attenuated cognitive decline was observed at higher levels of LC integrity in individuals with high cognitive reserve and elevated levels of FTP in entorhinal cortex compared to low FTP-tau/low CR (ß = -6.19, p<0.001) and low FTP-tau/high CR (ß = -6.72, p<0.001). Similar group comparisons were observed after grouping for tau in Braak stage 3 (ß = -10.78, p<0.001; ß = -10.37, p<0.001) and Braak stage 4 brain areas (ß = -9.61, p<0.001; ß = -8.80, p<0.001) and with PIB DVR (ß = -8.82, p<0.001; ß = -8.03, p<0.001).

Conclusion: These findings reveal that higher LC integrity may constitute a brain reserve measure bolstering CR in conferring resilience against cognitive decline in the face of elevated AD-pathology. Future research aims to extend this research to LC function and networks.

Download full-text PDF

Source
http://dx.doi.org/10.1002/alz.095547DOI Listing

Publication Analysis

Top Keywords

cognitive decline
12
cognitive reserve
8
mri-based integrity
8
cognition time
8
high pathology/high
8
pathology/high low
8
cognitive
6
integrity
5
developing topics
4
topics background
4

Similar Publications

Background: Plasma biomarkers demonstrated potential in identifying amyloid pathology in early Alzheimer's disease. Different subtypes of subjective cognitive decline (SCD) may lead to different cognitive impairment conversion risks.

Objective: To investigate the differences of plasma biomarkers in SCD subtypes individuals, which were unclear.

View Article and Find Full Text PDF

Background: White matter hyperintensities (WMH) are prominent neuroimaging markers of cerebral small vessel disease (CSVD) linked to cognitive decline. Nevertheless, the pathophysiological mechanisms underlying WMH remain unclear.

Objective: This study aimed to assess the structural decoupling index (SDI) as a novel metric for quantifying the brain's hierarchical organization associated with WMH in cognitively normal older adults

Methods: We analyzed data from 112 cognitively normal individuals with varying WMH burdens (43 high WMH burden and 69 low WMH burden).

View Article and Find Full Text PDF

Background: The aim of this study was to examine the potential added value of including neuropsychiatric symptoms (NPS) in machine learning (ML) models, along with demographic features and Alzheimer's disease (AD) biomarkers, to predict decline or non-decline in global and domain-specific cognitive scores among community-dwelling older adults.

Objective: To evaluate the impact of adding NPS to AD biomarkers on ML model accuracy in predicting cognitive decline among older adults.

Methods: The study was conducted in the setting of the Mayo Clinic Study of Aging, including participants aged ≥ 50 years with information on demographics (i.

View Article and Find Full Text PDF

Background: Alzheimer's disease (AD), the leading cause of dementia, is characterized by cognitive decline and the accumulation of amyloid-β (Aβ). It affects millions, with numbers expected to double by 2050. SMOC2, implicated in inflammation and fibrosis, may play a role in AD pathogenesis, particularly in microglial cell function, offering a potential therapeutic target.

View Article and Find Full Text PDF

This review examines the role of the canine blood-brain barrier (BBB) in health and disease, focusing on the impact of the multidrug resistance (MDR) transporter P-glycoprotein (P-gp) encoded by the gene. The BBB is critical in maintaining central nervous system homeostasis and brain protection against xenobiotics and environmental drugs that may be circulating in the blood stream. We revise key anatomical, histological and functional aspects of the canine BBB and examine the role of the gene mutation in specific dog breeds that exhibit reduced P-gp activity and disrupted drug brain pharmacokinetics.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!